The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence and predictors of ovarian function recovery (OFR) in exemestane patients with breast cancer (BC) with chemotherapy-induced amenorrhea (CIA) using two estradiol assays.
A. Guerrero-Zotano
No relevant relationships to disclose
J. Gavila
No relevant relationships to disclose
E. Folkerd
No relevant relationships to disclose
B. Ortiz
No relevant relationships to disclose
T. Labrador
No relevant relationships to disclose
F. Martinez
No relevant relationships to disclose
A. Garcia
No relevant relationships to disclose
M. A. Climent
No relevant relationships to disclose
V. Guillem
No relevant relationships to disclose
M. Dowsett
No relevant relationships to disclose
A. Ruiz
No relevant relationships to disclose